Bill Vick

This study aims to learn what people with idiopathic pulmonary fibrosis actually think about taking the medication(s) nintedanib (Ofev) and/or pirfenidone (Esbriet). This is not like other studies that may only focus on following doctors’ orders.&nbsp;

A Raremark study: What do you think about your IPF treatment(s)?

Pravin Pant

ASCEND-MG is a randomized, placebo-controlled study, testing an investigational medicine called RVT-1401 on adults with generalized myasthenia gravis (gMG).

Generalized myasthenia gravis (gMG) clinical research study (ASCEND-MG)

This placebo-controlled Phase 3 study is testing an investigational medicine called ravulizumab-cwvz, also known in this study as ALXN1210, on adults with anti-AChR antibody-positive, generalized myasthenia gravis (gMG).

Syneos_Alexion_CT_MG

Anti-AChR antibody-positive generalized myasthenia gravis clinical research study

This study aims to learn what people with sickle cell actually think about taking the newer sickle cell medications – Adakveo (crizanlizumab), Endari (L-glutamine), and Oxbryta (voxelotor) – and see how they compare with the older drug, hydroxyurea. This is not like other studies that may only focus on following doctors’ orders.

Get in touch

United States office

United Kingdom office